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Background/Purpose: The impact of provider volume, comorbidity and adverse outcomes on hospital
utilization of total hip arthroplasty (THA) has not yet been studied scientifically in Taiwan. This study
aimed to examine the relationship between surgeon/hospital volume, perioperative complications, acute
infections and hospital utilization for patients who underwent primary (THA).
Methods: We analyzed National Health Insurance (NHI) annual reimbursement data for all hospital ad-
missions due to primary THA between January 2005 and December 2006. A total of 9335 patients with
rheumatoid arthritis, osteoarthritis, avascular necrosis and other joint disorders were identified. Multivari-
ate regression analyses were used to assess the relationship between provider volume and hospital utilization
and the risk of adverse outcomes. Statistical analyses were adjusted for patient age, gender, comorbidity,
type of arthritis, as well as hospital attributes.
Results: Reversed linear associations were found among hospital utilization, surgeon volume, and comor-
bidity score. Patients with acute infection tended to stay 8 days more and cost NT$32,451 more than their
counterparts. Patients with perioperative complication tended to stay 2.30 days more and cost NT$15,327
more than their counterparts. Longer hospital stay and higher total hospital charge were associated with
patient’s age and Charlson index.
Conclusions: This study revealed that the volume of THAs performed by individual surgeons was a more
important determinant of hospital utilization than hospital volume. Perioperative adverse events were 
associated with patients’ age and comorbidity.
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Total hip arthroplasty (THA) has been proven to
be a very effective procedure for the treatment of
severe arthritis of the hip. The cost-effectiveness
of THA in reducing pain, increasing mobility,
restoring function, and further improving overall
patient health-related quality of life have been
well-documented.1−3 However, the expenditures
of THA have become a significant issue in the past
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decade. In Taiwan, the NHI had reported 6519 pri-
mary THA procedures in 2004, with an increased
rate of 2.1 percent.4 The numbers of primary THA
procedures increased substantially from 1990 to
2002 in the US,5 with their volume predicted to
double by the year 2026.6
Since the supply of modern surgical techniques
has improved and the aged population has in-
creased, THA procedures were expected to be aug-
mented. With an increased demand, the issue of
preserving limited healthcare resources for specific
groups of patients would be a mutual interest
among clinicians, hospital administrators and pol-
icy makers.7 The volume-outcome studies on total
joint arthroplasty reported that increased rates of
dislocation, infection, and death were associated
with lower provider volume after total joint arthro-
plasty.8,9 Higher rates of complications were found
at low-volume providers after total knee and shoul-
der arthroplasty.7,10−13 In addition, the relationship
between provider volume and economical out-
come has also been confirmed.14−16 Acute infec-
tion and perioperative complication are major
concerns with THA because of the great consump-
tion of hospital utilization and high morbidity
and mortality.8,9 However, there is limited infor-
mation about the impact of perioperative adverse
events on hospital costs and hospital days for 
patients who underwent elective primary THA.
The purposes of this study were to examine the
impact of surgeon or hospital volume on hospital
utilization; to explore the association of periop-
erative complication and acute infection with the
magnitude of hospital utilization among patients
who underwent primary THA, controlled for de-
mographic characteristics; and to identify the
major determinants that might explain the differ-
ences in hospital utilization.
Materials and Methods
Sample selection and exclusion criteria
This study used the National Health Insurance
Research Databases (NHIRD), provided by the
National Health Research Institute (NHRI), for the
calculation of hospital utilization, the estimation
of providers’ volume, and the index of comorbid-
ity. In June 2006, there were 22.3 million individ-
uals enrolled in the NHI with a coverage rate of
99%, and 18,289 healthcare providers contracted
with NHI, representing 91.5% of all providers in
Taiwan.17
We identified 10,236 cases of reimbursement
data and inpatient expenditures by admissions be-
tween January 2005 and December 2006, on the
basis of the International Classification of Diseases,
9th Revision, Clinical Modification (ICD-9-CM)
code for THA (81.51) listed as the major opera-
tion from two sources: NHI Hospital Database
and THA Inpatient Database. To minimize selec-
tion bias and data errors, serial exclusion criteria
were established (see Figure), i.e. primary or sec-
ondary diagnosis of osteomyelitis, or another type
of bone infection, fracture, tumor, or codes sug-
gestive of complications of a previous arthroplasty
(n=495); bilateral total hip arthroplasty (n=236);
THA with minor surgeries or procedures (n = 47);
treatment costs lower than NHI payment standard
(n = 123). Therefore, 9335 (91.2%) cases were 
included in the study population.
Outcome measures
The following outcomes reported in the NHIRD
were evaluated for the whole study population:
in-hospital adverse events, total hospital discharge,
and length of stay. For this study, in-hospital 
adverse events were defined as acute infection and
perioperative complications. Mortality was ex-
cluded as an outcome variable, because of a min-
imal incidence rate (0.02%). Acute infection was
defined as both cellulitis (ICD-9CM code: 682.2)
and wound infection (ICD-9CM code: 998.5) in
some studies.7,10 The indicators of perioperative
complications can be categorized as pulmonary
embolism,8,12 deep venous thrombosis,7,9 acute
myocardial infarction,12 pneumonia,12 urinary
tract infection9 and upper gastrointestinal bleed-
ing. Among the study population, however, the
above-mentioned complication cases were too few
to support multivariable logistic analysis. There-
fore, we aggregated the above adverse events as
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perioperative complications and acute infection,
which were coded dichotomously.
Provider volume measures
Hospital volume and surgeon volume were the
main exposure variables in the study, which were
defined as the total number of THA procedures
performed from 2005 to 2006 by a single surgeon
or hospital. Surgeon and hospital volumes were
divided into five groups based on the 20th, 40th,
60th, and 80th percentiles. Because of the small
number of patients treated by providers in the
lower volume groups, the bottom and middle two
groups were combined. Thus three groups were
defined: a low-volume group (< 40th percentile),
a medium-volume group (40–80th percentile),
and a high-volume group (> 80th percentile).13,20
Covariates measures
Patient-specific variables included age, gender,
arthritis diagnosis (i.e. rheumatoid arthritis, osteo-
arthritis, avascular necrosis and other joint disor-
ders) and comorbidity (the Charlson index, CCI,
modified by Deyo18). The CCI has been validated
as a proxy of illness severity in previous THA out-
come studies.9,10,13 Hospital-specific covariates
were ownership (public vs. private, and profit vs.
nonprofit) and hospital accreditation status (med-
ical center, regional hospital, and district hospital).
Statistical analyses
Descriptive statistics included means or percent-
ages and 95% confidence intervals. Analysis of
variance was adopted to examine the three volume
groups for statistical differences in continuous
variables (length of stay, total hospital charge).
Bivariate analyses were performed to measure the
association between surgeon and hospital case-
load and the remaining covariates. Multivariate
regression models were used to examine (after ad-
justing) age, gender, comorbidity, types of arthritis
diagnosis, as well as hospital attributes.
Length of stay and total hospital charge in the
hospital were treated as a continuous variable.
The presence or absence of an adverse event was
treated as a binary variable. Ordinary linear or
logistic regression requires that all observations
should be statistically independent of one another.
Figure. Serial exclusion criteria.
NHI (National Health Insurance)
Inpatient data claim data
Databases (2005–2006)
Inpatients with hip arthroplasty
(ICD-9-CM procedure code = 81.51)
10,236 patients
Exclude abnormal operation
fee and prosthesis fee
123 patients
Exclude infection, tumor
fracture or a complication
of previous arthroplasty 495
Excludes bilateral total
tip arthroplasty 236
Included in final study
sample 9335 patients (91.2%)
Exclude THA with
minor procedures 47
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This assumption was violated in our data because
multiple patients received care by the same sur-
geons/hospitals. Generalized estimating equa-
tions (Proc Genmod; SAS Institute, Gary, North
Carolina, USA) were therefore used to cluster pa-
tients within hospitals. Interaction between co-
variate, surgeon volume and hospital volume were
individually tested for every model. The interac-
tion term between hospital and surgeon volume
was also evaluated by entering it into the model
after all main effects had been included. None of
the interactions were found to reach significance.
The outcome rate of acute infection was not suf-
ficient to perform a regression analysis, because
of the relatively low rates in our datasets.
Results
Patient population and provider volume
In total, 715 orthopedic surgeons in 232 hospi-
tals performed THA for 9335 subjects, of which,
low-, medium-, and high-hospital volume groups
accounted for 272 (2.9%), 1914 (20.5%), and
7149 (76.4%), respectively. Low-, medium-, and
high-surgeon volume groups accounted for 451
(4.83%), 478 (26.55%), and 6406 (68.62%), re-
spectively. Patient volume distribution was skewed
in both surgeons and hospitals. Approximately
76.6% and 68.26% of THA procedures were per-
formed in 20% of the hospitals and by 20% 
(20) of the surgeons. Stratification of surgeon
volume revealed mean annual volumes of 1.03
(range 0.5–1.5), 4.8 (range 2–7.5) and 40.29
(range 8–119) in the low-, medium- and high-
volume surgeons, respectively (Table 2). Stratifi-
cation of hospital volume revealed mean annual
volumes of 4.33 (range 0.5–4), 25.43 (range
9–46) and 351.39 (range 23.5–577) in the low-,
medium- and high-volume hospitals, respectively
(Tables 1 and 2).
Table 1 indicates that the subjects treated by hos-
pitals from the high-volume group were younger
than those in medium- and low-volume groups
(p < 0.001). Compared with low-volume surgeons
and hospitals, medium- and high-volume surgeons
and hospitals treated a higher percentage of female
patients (p < 0.001). The patients treated by/at
lower surgeon/hospital volumes had higher CCI
(p < 0.05). Provider volume groups differed sig-
nificantly in terms of average length of stay and
total hospital charge (p < 0.001). Low-volume sur-
geons tended to have longer length of stay and
higher hospital charge than those of high-volume
groups. Patients treated at medium-volume hos-
pitals had longer length of stay and more hospital
charge than those of low-volume and high-volume
hospitals.
Models of medical utilization
A multivariate regression model was used to pre-
dict the length of stay and total hospital charge.
We found that surgeon volume, CCI score, acute
infection, and perioperative complication were
significantly related with both length of stay and
total hospital charge. In addition, linear but re-
verse associations among surgeon volume, length
of stay and total hospital charge were delineated.
The lengths of stay for subjects treated by high-/
medium-volume surgeons were −1.31 (p < 0.001)
and −0.66 days (p = 0.015) shorter than those of
their counterparts treated by low-volume surgeons,
after adjusting for case mix (Table 3). Similarly,
total hospital charge for subjects treated by/at
high-/medium-volume surgeons was NT$7056
(p < 0.000) and NT$4827 (p = 0.003) lower than
those of their counterparts treated by low-volume
surgeons. Total hospital charge for subjects treated
at high-/medium-volume hospitals was NT$199
(p = 0.894) and NT$1581 (p = 0.246) more than
those of their counterparts treated at low-volume
hospitals and the lengths of stay for subjects
treated were −0.32 (p = 0.344) and 0.35 days (p =
0.286) less than those of their counterparts treated
at low-volume hospitals, but these differences did
not reach significance.
Increased severity of comorbidities and age
among the subjects were positively associated
with the length of stay and total hospital charge
(Table 3). Subjects with CCI ≥ 2 tended to have
1.61 days longer hospital stay and NT$14,365
higher hospital charge than those of CCI = 0. 
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The increment of age also had a significant effect
on total hospital charge (NT$75/year) and length
of stay (0.02 days/year). However, no significant
association between gender and hospital utiliza-
tion was found. In addition, no significant effects
of osteoarthritis, rheumatoid arthritis and avascular
necrosis on length of stay and total hospital charge
were found; nevertheless, diagnosis of other joint
disease tended to have a significant effect on length
of stay and total hospital charge.
Subjects with acute infection and perioperative
complication also had significant effects on length
Table 1. Comparison of patient and provider characteristics among three hospital volume groupsa
Characteristics Low volume Medium volume High volume p
No. of patients 272 (2.92) 1914 (20.50) 7149 (76.58)
No. of hospitals 92 (39.65) 93 (40.09) 47 (20.26)
Average annual volume of patients 0.5–4 4.5–23 23.5–577
undergoing THA per hospital
Annual volume of patients undergoing 2.16 ± 1.00 12.76 ± 5.12 175.65 ± 187.02
THA per hospital
Age of patients (yr) 57.61 ± 15.94 57.57 ± 14.33 56.62 ± 14.61 0.027
No. of females 104 (38.24) 723 (37.77) 3315 (46.37) < 0.001
No. of patients by diagnosis
Avascular necrosis 118 (43.38) 957 (50) 3333 (46.62)
Osteoarthritis 146 (53.68) 902 (47.13) 3480 (48.68) 0.002
Rheumatoid arthritis 1 (0.37) 16 (0.83) 35 (0.48)
Other 7 (2.57) 39 (2.04) 237 (3.32)
No. of Charlson Comorbidity Index 
scores
Mean ± SD 0.25 ± 0.82 0.28 ± 0.69 0.23 ± 0.60 0.015
0 236 (86.76) 1556 (81.30) 5910 (82.67)
1 24 (8.82) 250 (13.06) 971 (13.58) < 0.001
≥ 2 12 (4.42) 108 (5.64) 268 (3.75)
No. of patients by hospital level
Medical center 0 68 (3.55) 4279 (59.85)
Regional hospital 42 (15.44) 1007 (52.62) 1815 (25.39) < 0.001
District hospital 230 (84.56) 839 (43.83) 1055 (14.76)
No. of patients by hospital ownership 
structure
Public 63 (23.16) 680 (35.53) 2103 (29.42)
Nonprofit 154 (56.62) 543 (28.37) 1402 (19.61) < 0.001
For profit 55 (20.22) 691 (36.10) 3644 (50.97)
Average length of hospital stay 8.74 ± 3.25 9.00 ± 3.93 7.41 ± 3.21 < 0.001
95% confidence interval 8.35–9.13 8.83–9.18 7.34–7.49
Total charges in NT$, 111,089 ± 14,565 112,309 ± 17, 287 109,864 ± 18,002 0.006
Inflation-adjusted
No. of acute infections 0 (0) 12 (0.63) 23 (0.32) 0.09
No. of perioperative complications 6 (2.21) 37 (1.93) 98 (1.37) 0.127
aData are presented as mean ± standard deviation, n (%) or range. THA = total hip arthroplasty; SD = standard deviation.
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of stay and total hospital charge. Subjects with
acute infection required 8.21 more days of hospi-
talization and NT$32,451 extra charge than their
counterparts. Subjects with perioperative com-
plication required 2.30 more days of hospitaliza-
tion and NT$15,327 extra charge than their
counterparts.
Adverse-outcomes models
A total of 35 (0.37%) subjects had acute infection
during their hospitalization, while 141 (1.51%)
subjects had perioperative complications. Multi-
variate analyses demonstrated that subjects’ age
and CCI were significant predictors of perioperative
complication. However, no significant predictors
Table 2. Patient and provider characteristics for three surgeon volume groupsa
Characteristics Low volume Medium volume High volume p
No. of patients 451 (4.83) 2478 (26.55) 6406 (68.62)
No. of surgeons 264 (36.92) 302 (42.24) 149 (20.84)
Average volume range of patients 0.5–1.5 2–7.5 8–119
undergoing THA per year
Annual volume of patients undergoing 1.03 ± 0.40 4.8 ± 1.76 40.29 ± 34.13
THA per surgeon
Age of patients (yr) 57.24 ± 15.34 56.88 ± 14.61 56.80 ± 14.54 0.818
No. of females 163 (36.14) 949 (38.30) 3030 (47.30) < 0.001
No. of patients by diagnosis
Avascular necrosis 218 (48.34) 1224 (49.39) 2966 (46.30)
Osteoarthrosis 220 (48.77) 1170 (47.22) 3138 (48.99) 0.024
Rheumatoid arthritis 4 (0.89) 26 (1.05) 86 (1.31)
Other 9 (2.00) 62 (2.34) 218 (3.40)
Charlson Comorbidity Index scores
Mean 0.32 ± 0.80 0.26 ± 0.67 0.23 ± 0.60 0.013
0 363 (80.49) 2031 (81.96) 5308 (82.86)
1 57 (12.64) 325 (13.12) 863 (13.47) 0.003
≥ 2 31 (6.87) 122 (4.92) 235 (3.67)
No. of patients by hospital level
Medical center 106 (23.50) 616 (24.86) 3625 (56.59)
Regional hospital 164 (36.36) 1060 (42.78) 1640 (25.60) < 0.001
District hospital 181 (40.14) 802 (32.36) 1141 (17.81)
No. patients by hospital ownership 
structure
Public 146 (32.37) 758 (30.59) 1942 (30.32)
Nonprofit 163 (36.14) 676 (27.28) 1260 (19.67) < 0.001
For profit 142 (31.49) 1044 (42.13) 3204 (50.01)
Average length of hospital stay 9.18 ± 4.50 8.72 ± 3.58 7.32 ± 3.18 < 0.001
95% confidence interval 8.77–9.60 8.58–8.86 7.24–7.39
Total charges in NT$, 116,708 ± 28,294 112,470 ± 14,724 109,157 ± 177,552 < 0.001
Inflation-adjusted
No. of acute infections 6 (1.33) 12 (0.48) 17 (0.27) 0.001
No. of perioperative complications 8 (1.77) 47 (1.90) 86 (1.34) 0.0142
aData are presented as n (%), mean ± standard deviation or range. THA = total hip arthroplasty; SD = standard deviation.
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were found in terms of provider volume indica-
tors. The likelihood of perioperative complications
among subjects with CCI score ≥ 2 and equal to 1
were 8.22 (p < 0.000) and 2.09 (p = 0.000) times
greater than those of subjects with CCI score = 0,
respectively (Table 4).
Discussion
Effect of provider volume on economical
outcomes
Subjects treated by higher volume surgeons tended
to have less total hospital charge and shorter
length of stay than their counterparts after adjust-
ing for patients’ age, gender, comorbidity, type of
arthritis diagnosed, as well as hospital attributes.
Our findings are consistent with those of previ-
ous volume-outcome studies that demonstrated
a reverse relationship between surgeon provider
volume and hospital utilization.7,9,13 Although
total hospital charge was greater in higher vol-
ume hospitals and length of stay was longer in
medium-volume hospitals compared with low-
volume and high-volume hospitals, these trends
did not reach significance. Individual surgeon
experience rather than hospital factors were,
therefore, significantly associated with hospital
utilization. This finding suggests that the hospi-
tal services, protocols, and standards did not 
appear to affect the hospital utilization as much
as the experience of individual surgeons. In our
Table 3. Predictors of average length of stay and total charge
Average length of stay Total charge
Predictor
Estimate 95% CI p Estimate 95% CI p
Surgeon volume
Low (reference)
Moderate −0.66 −1.20 to −0.13 0.015 −4827 −1605 to −8049 0.003
High −1.13 −1.65 to −0.61 < 0.000 −7056 −3767 to −10,344 < 0.00
Hospital volume
Low (reference)
Moderate 0.35 −0.29 to 0.99 0.286 1581 −1088 to 4249 0.246
High −0.32 −1.00 to 0.35 0.344 199 −2735 to 3132 0.894
Charlson comorbidity 
index scores
0 (reference)
1 0.59 0.39–0.80 < 0.0001 4068 2885–5250 < 0.00
≥ 2 1.61 0.98–2.24 < 0.0001 14,365 10,396–18,334 < 0.00
Complication (yes) 2.30 0.97–3.64 0.001 15,327 6076–24,579 0.001
Infection (yes) 8.21 3.62–12.80 0.001 32,451 13,384–51,519 0.001
Age 0.02 0.01–0.02 < 0.0001 75 26–124 0.003
Sex
Male (reference)
Female 0.03 −0.11 to 0.18 0.658 −510 −1238 to 219 0.170
Diagnosis
AVN (reference)
Osteoarthritis 0.04 −0.14 to 0.22 0.689 520 −516 to 1556 0.325
Rheumatoid arthritis −0.17 −0.64 to 0.31 0.492 −1750 −4075 to 575 0.140
Other 0.68 0.12–1.24 0.017 7450 4319 to 10,581 < 0.00
Predictors of average length of hospital stay and total hospital charge controlled for hospital ownership (public, nonprofit, and for profit)
and hospital accreditation level (medical center, regional hospital, and district hospital). AVN=avascular necrosis; CI= confidence interval.
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study, we found that THA procedures in Taiwan
were mainly performed by high-volume providers
(Tables 1 and 2), which tended to consume less
hospital utilization (i.e. shorter length of stay and
lower total hospital charge). Thus, the surgeon
volume of THA can serve as a proxy of a cost con-
tainment indicator for third-party payers.
Effect of comorbidity on economical and
medical outcomes
In our study, comorbidity had a profound effect on
both hospital utilization and medical outcomes.
Subjects with CCI ≥ 2 tended to cost an extra
NT$14,365 and stayed in hospital 1.61 more
days than subjects with CCI = 0. This finding is
consistent with previous studies.19 In addition, the
risk of perioperative complication for subjects with
CCI ≥ 2 were 8.22 and 2.09 times greater than
those of subjects with CCI = 0. Previously, patients
with a CCI > 2 have been reported to have a 6.5
times greater risk of dying within 90 days after
surgery.20 Kreder found that patients with CCI ≥ 2
were 24 times more likely to die within 3 months
after admission, and were twice as likely to suffer
in-hospital complications.9 Thus, we concur that
CCI is an effective instrument for surgeons, hos-
pitals and healthcare systems to identify patients
and/or groups of patients at high risk of medical
resource consumption and adverse outcomes.
Effect of medical outcomes on economical
outcomes
In addition to provider volume, this study delin-
eated that acute infection and perioperative com-
plication also had a significant effect on length
of stay and total hospital charge. The occurrences
of acute infection and perioperative complica-
tion increased the length of stay by 8.22 and 2.09
days and total hospital charge by NT$32,451 and
NT$14,365, respectively. These findings revealed
that the magnitude of effects of acute infection
and perioperative complication on length of stay
and total hospital charge were even greater than
those of provider volume.
Though the incidence rates of acute infection
and perioperative complication were slim in our
study (0.37% and 1.51%), with the latter being
five times greater than the former. Nevertheless,
the magnitude of effect of acute infection on length
of stay was almost four fold that of perioperative
complication (8.22 vs. 2.09 days); and the magni-
tude of effect of acute infection on total hospital
charge was double that of perioperative compli-
cation (NT$32,451 vs. NT$14,365). A previous
study demonstrated that the treatment for infected
THA is significantly associated with greater resource
utilization, compared with the treatment for re-
vision THA because of aseptic loosening or pri-
mary THA.21 Therefore, avoiding acute infection
would be the rule of thumb for reducing hospital
utilization and medical resource consumption.
This study confirmed the significant relation-
ships between provider volume and economical
Table 4. Predictors of perioperative complications
Predictor OR 95% CI p
Surgeon volume
High 0.92 0.39–2.19 0.854
Moderate 1.12 0.50–2.52 0.778
Low (reference)
Hospital volume
High 0.67 0.19–2.40 0.542
Moderate 0.80 0.25–2.53 0.669
Low (reference)
Charlson comorbidity 
index scores
0 (reference)
1 2.09 1.44–3.04 0.000
≥ 2 8.22 4.75–14.22 < 0.000
Age 1.02 1.01–1.04 0.002
Sex
Male (reference)
Female 1.51 0.96–2.39 0.077
Diagnosis
AVN (reference)
Osteoarthritis 1.28 0.96–1.70 0.096
Rheumatoid arthritis 0.99 0.35–2.84 0.987
Other 0.31 0.06–1.78 0.19
Perioperative complication as event controlled for hospital ownership
(public, nonprofit and for profit), and hospital accreditation level (med-
ical center, regional hospital and district hospital). AVN = avascular
necrosis; OR = odds ratio; CI = confidence interval.
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and medical outcomes, and also found significant
associations among hospital utilization, CCI, and
provider volume. The occurrence of perioperative
complication and acute infection also had signif-
icant influence on hospital utilization, particularly
acute-operative infection.
The major strength of our study was the large
population-based sample; however, there are some
limitations in our study. First, the claim data were
not originally designed for clinical research and
was thus unable to measure functional outcomes,
pain relief, and/or patient satisfaction. Second, the
present study did not define the minimally accept-
able volume thresholds, and the volume cutoff
points were based on the quartiles. Lastly, co-
morbidity and adverse events were derived from
secondary diagnostic codes, which may not be re-
corded correctly, and their incidence may be over-
estimated. Fortunately, miscoding would happen
systematically and the bias would be minimal.
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